| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 750 | ₹0.3 -70% | 7,7500% |
| - | - | 770 | ₹0.55 0% | 4,6500% |
| 89,9000% | ₹154.15 0% | 800 | ₹1.15 -36.11% | 29,4502.70% |
| - | - | 820 | ₹3.5 0% | 7750% |
| 4,6500% | ₹130.1 0% | 830 | ₹0.65 -82.66% | 6,97512.5% |
| 59,6750% | ₹114.75 4.5% | 840 | ₹1.5 -50% | 17,825-4.16% |
| 37,2000% | ₹109.7 0% | 850 | ₹1.6 -52.94% | 64,325-15.30% |
| 7750% | ₹78.35 0% | 860 | ₹2.9 -30.12% | 13,9500% |
| 7750% | ₹72 0% | 870 | ₹3.05 -33.69% | 13,950-25% |
| 1,5500% | ₹81.5 0% | 880 | ₹3.4 -45.6% | 30,225-31.57% |
| 00% | ₹73.75 0% | 890 | ₹4.75 -32.62% | 19,37519.04% |
| 1,94,5250% | ₹70.35 16.76% | 900 | ₹6 -36.84% | 1,52,675-2.47% |
| 3,8750% | ₹60 0% | 910 | ₹12 0% | 7750% |
| 20,1500% | ₹46.05 0% | 920 | ₹9.75 -34.56% | 42,625-12.69% |
| 87,5755.60% | ₹46.4 17.76% | 930 | ₹12.5 -31.69% | 79,825-12.71% |
| 51,150-7.04% | ₹39.95 20.51% | 940 | ₹15.3 -31.23% | 54,25012.90% |
| 1,43,37512.80% | ₹34.1 19.02% | 950 | ₹19 -29.62% | 81,375-10.25% |
| 1,89,87531.01% | ₹28.4 19.32% | 960 | ₹23.25 -27% | 63,5500% |
| 48,825-4.54% | ₹23.2 17.46% | 970 | ₹30.5 -41.9% | 12,40045.45% |
| 52,70021.42% | ₹18.7 17.61% | 980 | ₹52.5 0% | 16,2750% |
| 27,900-14.28% | ₹15.1 27.96% | 990 | - | - |
| 2,54,975-8.10% | ₹11.9 14.97% | 1,000 | ₹48.7 -16.17% | 40,3004% |
| 74,400-6.79% | ₹9.3 30.06% | 1,010 | - | - |
| 54,250125.80% | ₹7.1 46.39% | 1,020 | ₹94 0% | 5,4250% |
| 1,61,97535.71% | ₹5.6 17.89% | 1,030 | - | - |
| 2,11,575162.5% | ₹4.2 13.51% | 1,040 | ₹94.65 0% | 6,2000% |
| 1,61,97537.5% | ₹2.2 7.31% | 1,060 | - | - |
| 7750% | ₹2 0% | 1,080 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Reg. No. INM000010940, SEBI RA Regn. No: INH000000248, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
